NNVC
NNVC
AMEX · Biotechnology

Nanoviricides Inc

$0.91
-0.05 (-5.59%)
Financial Highlights (FY 2025)
Revenue
9.32M
Net Income
712.1K
Gross Margin
56.7%
Profit Margin
7.6%
Rev Growth
+16.1%
D/E Ratio
1.16
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 56.7% 56.7% 56.7%
Operating Margin 7.8% 7.9% 7.0%
Profit Margin 7.6% 7.0% 6.7%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 9.32M 9.26M 9.19M
Gross Profit 5.28M 5.24M 5.20M
Operating Income 726.1K 727.7K 638.7K
Net Income 712.1K 643.5K 610.9K
Gross Margin 56.7% 56.7% 56.7%
Operating Margin 7.8% 7.9% 7.0%
Profit Margin 7.6% 7.0% 6.7%
Rev Growth +16.1% +5.9% +8.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 9.12M 8.03M 7.99M
Total Equity 7.88M 7.30M 6.95M
D/E Ratio 1.16 1.10 1.15
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 971.8K 983.2K 961.2K
Free Cash Flow 631.5K 606.6K 819.9K